Prognostic importance of lymphovascular invasion in urothelial carcinoma of the renal pelvis

The current study was conducted to assess the impact of lymphovascular invasion on the survival of patients with urothelial carcinoma of the renal pelvis.

[1]  J. Coleman,et al.  Association between lymph node yield and survival among patients undergoing radical nephroureterectomy for urothelial carcinoma of the upper tract , 2017, Cancer.

[2]  K. Bensalah,et al.  Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy , 2017, World Journal of Urology.

[3]  Sanjay G. Patel,et al.  The effect of surgical approach on performance of lymphadenectomy and perioperative morbidity for radical nephroureterectomy. , 2016, Urologic oncology.

[4]  Miao-Fen Chen,et al.  The Efficacy of Postoperative Adjuvant Chemotherapy for Patients with pT3N0M0 Upper Tract Urothelial Carcinoma. , 2015, The Journal of urology.

[5]  Sanjay G. Patel,et al.  Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides. , 2015, European urology.

[6]  P. Hegde,et al.  MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer , 2014, Nature.

[7]  Steven L. Chang,et al.  A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma. , 2014, European urology.

[8]  Jonathan Izawa,et al.  Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract Collaboration. , 2014, Urologic oncology.

[9]  Steven L. Chang,et al.  Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials. , 2014, European urology.

[10]  M. Babjuk,et al.  Perioperative chemotherapy in muscle-invasive bladder cancer: overview and the unmet clinical need for alternative adjuvant therapy as studied in the MAGNOLIA trial. , 2014, European Urology.

[11]  C. Kwak,et al.  Prognostic Significance of Lymphovascular Invasion in Radical Cystectomy on Patients with Bladder Cancer: A Systematic Review and Meta-Analysis , 2014, PloS one.

[12]  C. Kwak,et al.  Lymphovascular invasion as a prognostic factor in the upper urinary tract urothelial carcinoma: a systematic review and meta-analysis. , 2013, European journal of cancer.

[13]  S. Culine,et al.  Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  K. Bensalah,et al.  Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. , 2013, The Journal of urology.

[15]  E. Hall,et al.  Time to define an international standard of postoperative care for resected upper urinary tract transitional cell carcinoma (TCC) – opening of the peri‐operative chemotherapy versus surveillance in upper tract urothelial cancer (POUT) Trial , 2012, BJU international.

[16]  J. McKiernan,et al.  Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion , 2012, BJU international.

[17]  K. Bensalah,et al.  Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  M. Dimopoulos,et al.  Outcomes after adjuvant chemotherapy in the treatment of high‐risk urothelial carcinoma of the upper urinary tract (UUT‐UC) , 2011, Cancer.

[19]  J. Raman,et al.  Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973–2005 , 2011, BJU international.

[20]  M. Stifelman,et al.  Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. , 2010, European urology.

[21]  F. Montorsi,et al.  Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. , 2010, The Journal of urology.

[22]  S. Shariat,et al.  Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. , 2010, European urology.

[23]  V. Margulis,et al.  Adjuvant chemotherapy for high-risk upper tract urothelial carcinoma: Results from the Upper Tract Urothelial Carcinoma Collaboration. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Y. Lotan,et al.  Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration , 2009, Cancer.

[25]  K. Bensalah,et al.  Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J. Patard,et al.  356 INDEPENDENT PREDICTORS OF CANCER-SPECIFIC SURVIVAL IN TRANSITIONAL CELL CARCINOMA OF THE UPPER URINARY TRACT: MULTI-INSTITUTIONAL DATASET FROM 3 EUROPEAN CENTERS , 2007 .

[27]  Y. Lotan,et al.  Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  M. Dimopoulos,et al.  Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  C. Cass,et al.  Gastric Cancer: Establishing Predictors of Biologic Behavior with Use of Population-Based Data , 2004, Annals of Surgical Oncology.

[30]  M. Silverstein,et al.  Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer. , 2002, American journal of surgery.

[31]  T. Carmody,et al.  Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. , 1998, Urology.